Koninklijke Philips N.V. (Netherlands) and ResMed (US) are Leading Players in the Sleep Apnea Devices Market
The sleep apnea devices market is valued at an estimated USD 6.5 billion in 2024 and is projected to reach USD 9.3 billion by 2029 at a CAGR of 7.3% during the forecast period. The growth of this market is mainly driven by innovations in sleep apnea devices such as advancement in CPAP machines and wearable diagnostics.
The key players in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Limited (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Openairway (Canada), Compumedics Limited (Australia), Löwenstein Medical Technology GmbH + Co. K.G. (Germany), Drive DeVilbiss Healthcare (US), BMC Medical Co., Ltd. (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. Kg (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US).
To know about the assumptions considered for the study download the pdf brochure
For the year 2023, ResMed (US) held the highest market share sleep apnea devices market. The company is known for its innovative and well-advanced sleep apnea therapeutic and diagnostic devices. The company is focused on using its healthcare technology expertise for accurate and efficient sleep apnea devices that helps it in gaining significant market share. The company has also extended its sleep apnea product offering including PAP devices and facial interfaces in past few years, which has helped it retain its market leadership.
In 2023, Koninklijke Philips N.V. (Netherlands) held for the second-largest share of the sleep apnea devices market in 2023. The company is a leading player in the sleep apnea devices market, renowned for its innovative and user-friendly health monitoring devices. The company is expanding its global presence by strategic partnerships and acquisitions, which increases accessibility and awareness of sleep apnea solutions in emerging and developing markets.
In 2023, Fisher & Paykel Healthcare Limited (New Zealand) was estimated to hold the third-largest share of the sleep apnea devices market in 2023. The company’s Hospitals segment and Homecare segments are responsible for selling sleep apnea devices. Fisher & Paykel Healthcare Limited is more focused on increasing their product offering in the sleep apnea devices market by developing products with advanced humidification and mask technologies which in turn improve patient comfort and therapeutic effectiveness.
Related Reports:
Sleep Apnea Devices Market by products (Therapeutic (PAP (CPAP, APAP, BPAP)), Facial Interfaces, Oral Appliances, Accessories), Diagnostic Devices (PSG, Home Sleep Testing, Oximeters), Age Group, Gender type, End User & Region - Global Forecasts to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
